rs41302375

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_004621.6(TRPC6):​c.-361A>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.228 in 215,138 control chromosomes in the GnomAD database, including 6,110 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4258 hom., cov: 32)
Exomes 𝑓: 0.23 ( 1852 hom. )

Consequence

TRPC6
NM_004621.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.06
Variant links:
Genes affected
TRPC6 (HGNC:12338): (transient receptor potential cation channel subfamily C member 6) The protein encoded by this gene forms a receptor-activated calcium channel in the cell membrane. The channel is activated by diacylglycerol and is thought to be under the control of a phosphatidylinositol second messenger system. Activation of this channel occurs independently of protein kinase C and is not triggered by low levels of intracellular calcium. Defects in this gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 11-101583864-T-A is Benign according to our data. Variant chr11-101583864-T-A is described in ClinVar as [Benign]. Clinvar id is 301926.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TRPC6NM_004621.6 linkuse as main transcriptc.-361A>T 5_prime_UTR_variant 1/13 ENST00000344327.8 NP_004612.2 Q9Y210-1
TRPC6XM_047427510.1 linkuse as main transcriptc.-361A>T 5_prime_UTR_variant 1/11 XP_047283466.1
TRPC6XM_017018221.3 linkuse as main transcriptc.-361A>T 5_prime_UTR_variant 1/11 XP_016873710.1 Q9Y210-2
TRPC6XM_047427509.1 linkuse as main transcriptc.-89+68A>T intron_variant XP_047283465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TRPC6ENST00000344327.8 linkuse as main transcriptc.-361A>T 5_prime_UTR_variant 1/131 NM_004621.6 ENSP00000340913.3 Q9Y210-1
TRPC6ENST00000526713.1 linkuse as main transcriptn.266-79066A>T intron_variant 3

Frequencies

GnomAD3 genomes
AF:
0.228
AC:
34557
AN:
151848
Hom.:
4260
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.202
Gnomad AMI
AF:
0.519
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.279
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.135
Gnomad FIN
AF:
0.276
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.261
Gnomad OTH
AF:
0.245
GnomAD4 exome
AF:
0.229
AC:
14481
AN:
63172
Hom.:
1852
Cov.:
0
AF XY:
0.229
AC XY:
7242
AN XY:
31560
show subpopulations
Gnomad4 AFR exome
AF:
0.191
Gnomad4 AMR exome
AF:
0.178
Gnomad4 ASJ exome
AF:
0.279
Gnomad4 EAS exome
AF:
0.000414
Gnomad4 SAS exome
AF:
0.115
Gnomad4 FIN exome
AF:
0.255
Gnomad4 NFE exome
AF:
0.258
Gnomad4 OTH exome
AF:
0.211
GnomAD4 genome
AF:
0.227
AC:
34555
AN:
151966
Hom.:
4258
Cov.:
32
AF XY:
0.226
AC XY:
16815
AN XY:
74278
show subpopulations
Gnomad4 AFR
AF:
0.202
Gnomad4 AMR
AF:
0.185
Gnomad4 ASJ
AF:
0.279
Gnomad4 EAS
AF:
0.00116
Gnomad4 SAS
AF:
0.135
Gnomad4 FIN
AF:
0.276
Gnomad4 NFE
AF:
0.261
Gnomad4 OTH
AF:
0.242
Alfa
AF:
0.232
Hom.:
552
Bravo
AF:
0.222
Asia WGS
AF:
0.0730
AC:
254
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 20, 2019- -
Focal segmental glomerulosclerosis 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.24
CADD
Benign
19
DANN
Benign
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41302375; hg19: chr11-101454595; API